Beijing Leadman Biochemistry Co Ltd - ESG Rating & Company Profile powered by AI
The report of Beijing Leadman Biochemistry Co Ltd uses data from across the web and also from available filings by Beijing Leadman Biochemistry Co Ltd. This SDG rating for Beijing Leadman Biochemistry Co Ltd indicates its reporting of the United Nations Sustainable Development Goals. Browse to the bottom of this page for potential risks for Beijing Leadman Biochemistry Co Ltd based on industry, location and marketcap.
Beijing Leadman Biochemistry Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Beijing Leadman Biochemistry Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Beijing Leadman Biochemistry Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Beijing Leadman Biochemistry Co Ltd disclose current and historical energy intensity?
Does Beijing Leadman Biochemistry Co Ltd report the average age of the workforce?
Does Beijing Leadman Biochemistry Co Ltd reference operational or capital allocation in relation to climate change?
Does Beijing Leadman Biochemistry Co Ltd disclose its ethnicity pay gap?
Does Beijing Leadman Biochemistry Co Ltd disclose cybersecurity risks?
Does Beijing Leadman Biochemistry Co Ltd offer flexible work?
Does Beijing Leadman Biochemistry Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Beijing Leadman Biochemistry Co Ltd disclose the number of employees in R&D functions?
Does Beijing Leadman Biochemistry Co Ltd conduct supply chain audits?
Does Beijing Leadman Biochemistry Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Beijing Leadman Biochemistry Co Ltd conduct 360 degree staff reviews?
Does Beijing Leadman Biochemistry Co Ltd disclose the individual responsible for D&I?
Does Beijing Leadman Biochemistry Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Beijing Leadman Biochemistry Co Ltd disclose current and / or historical scope 2 emissions?
Does Beijing Leadman Biochemistry Co Ltd disclose water use targets?
Does Beijing Leadman Biochemistry Co Ltd have careers partnerships with academic institutions?
Did Beijing Leadman Biochemistry Co Ltd have a product recall in the last two years?
Does Beijing Leadman Biochemistry Co Ltd disclose incidents of discrimination?
Does Beijing Leadman Biochemistry Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has Beijing Leadman Biochemistry Co Ltd issued a profit warning in the past 24 months?
Does Beijing Leadman Biochemistry Co Ltd disclose parental leave metrics?
Does Beijing Leadman Biochemistry Co Ltd disclose climate scenario or pathway analysis?
Does Beijing Leadman Biochemistry Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Beijing Leadman Biochemistry Co Ltd disclose the pay ratio of women to men?
Does Beijing Leadman Biochemistry Co Ltd support suppliers with sustainability related research and development?
Does Beijing Leadman Biochemistry Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Beijing Leadman Biochemistry Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Beijing Leadman Biochemistry Co Ltd involved in embryonic stem cell research?
Does Beijing Leadman Biochemistry Co Ltd disclose GHG and Air Emissions intensity?
Does Beijing Leadman Biochemistry Co Ltd disclose its waste policy?
Does Beijing Leadman Biochemistry Co Ltd report according to TCFD requirements?
Does Beijing Leadman Biochemistry Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Beijing Leadman Biochemistry Co Ltd disclose energy use targets?
Does Beijing Leadman Biochemistry Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Beijing Leadman Biochemistry Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Beijing Leadman Biochemistry Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Beijing Leadman Biochemistry Co.,Ltd. engages in the research and development, manufacture, and sale of in vitro diagnostic products in the People's Republic of China. The company offers biochemical raw materials, such as enzymes, coenzymes, antibodies, buffers, enzyme substrates, culture media, stain reagents, amino acids, and other products primarily for biotechnology, clinical diagnosis, drug development, chemical production, and other related applications. It also provides biochemistry diagnostic and companion reagents. In addition, the company offers medical instruments, such as EnigmaML, an automated molecular test platform for use in clinical laboratory and at the point-of-care, including clinics, doctor's surgeries, and pharmacies; DiaSys InnovaStar, an automatic compact POCT analyzer to deliver result quality comparable to measurements on laboratory analyzers; DiaSys Respons, a random access bench top analyzer; CI1000 automatic chemiluminescence immunoassay analyzers; and IDS-isys, an instrument to enhance performance and productivity. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.